Sun Pharma, Lupin, and Dr Reddy's are recalling various drugs from the US market due to manufacturing issues and product mix-ups, as per the USFDA.

Sun Pharmaceutical Industries, headquartered in Mumbai, is recalling 5,448 bottles of a generic drug used to treat Attention ...

Three major Indian pharmaceutical companies are recalling drugs in the United States. Sun Pharma is recalling ...

Indian pharmaceutical giants Sun Pharma, Lupin and Dr Reddy's Laboratories are recalling drugs from the US market due to ...

Top pharma players Dr Reddy, Lupin, and Sun Pharma are reportedly recalling drugs from the US market as a result of manufacturing faults an product mix up, as per the US Food and Drug Administration ...

Sun Pharma recalls Dimesylate capsules, Lupin recalls Lisinopril and Hydrochlorothiazide tablets, and Dr Reddy’s recall ...

Indian pharmaceutical companies Sun Pharma, Lupin, and Dr Reddy's Laboratories are conducting recalls in the US due to ...

Domestic drug majors Sun Pharma, Lupin and Dr Reddy's Laboratories are recalling drugs in the US market due to manufacturing ...

Dr Reddy’s Laboratories invests Rs 565 crore in Russian subsidiary, acquiring 45.19% stake for working capital needs.

Detailed price information for Dr. Reddy's Laboratories Ltd ADR (RDY-N) from The Globe and Mail including charting and trades.

Detailed price information for Dr. Reddy's Laboratories Ltd ADR (RDY-N) from The Globe and Mail including charting and trades.